BENGALURU (Reuters) - The Serum Institute of India said it will partner with the Bill & Melinda Gates Foundation and international vaccine alliance GAVI to manufacture and deliver 100 million COVID-19 vaccine doses for India and other low- and middle-income nations as early as 2021.
The institute said on Friday it will get funding to support manufacturing for candidate vaccines from AstraZeneca (NYSE:AZN) and Novavax (NASDAQ:NVAX).